Introduction
Methods
Study design and participants
Measures
Validation dataset
Statistics
Results
Participant characteristics
Dutch database (n = 337) | US database (n = 252) | P-value | |
---|---|---|---|
Sex, n (%) | 0.242 | ||
Male | 59 (17.5) | 31 (12.3) | |
Female | 276 (81.9) | 215 (85.3) | |
Other/I don’t want to say | 2 (0.6) | 6 (2.4) | |
Age, years | 55 (44–63) | 50 (38–58)# | < 0.001 |
BMI, kg/m2 | 23.9 (21.1–27.8) | – | |
Ethnicity, n (%) | 0.579 | ||
Black, African-American | 1 (0.3) | – | |
White | 327 (97.0) | 245 (97.2) | |
American Indian or Alaska Native | – | 1 (0.4) | |
Asian or Pacific Islander | 2 (0.6) | 3 (1.2) | |
Other | 7 (2.1) | 3 (1.2) | |
Marital status, n (%) | # | < 0.001 | |
Married or living with partner | 185 (54.9) | 121 (48.0) | |
Living alone | 127 (37.7) | 77 (30.6) | |
Widow(er)/divorced | 25 (7.4) | 54 (21.4) | |
Children, n (%) | 0.770 | ||
Yes | 159 (47.2) | 121 (48.0) | |
Education level, n (%)a | # | 0.001 | |
Low | 10 (3.0) | 10 (4.0) | |
Medium | 127 (37.7) | 62 (24.6) | |
High | 195 (57.9) | 178 (70.6) | |
Other/I don’t want to say | 5 (1.5) | 2 (0.8) | |
Current work status, n (%)b | # | < 0.001 | |
On disability | 215 (63.8) | 118 (46.8) | |
Student | 6 (1.8) | 15 (6.0) | |
Homemaker | 26 (7.7) | 13 (5.2) | |
Retired | 58 (17.2) | 34 (13.5) | |
Unemployed | 23 (6.8) | 35 (13.9) | |
Working part-time | 57 (16.9) | 39 (15.5) | |
Working full-time | 9 (2.7) | 20 (7.9) | |
Case definition, n (%)c | # | < 0.001 | |
Fukuda criteria | 302 (89.6) | 234 (92.9) | |
Canadian clinical ME/CFS criteria | 197 (58.5) | 198 (78.6) | |
International consensus criteria | 131 (38.9) | 162 (64.3) | |
Institute of medicine | 270 (80.1) | 226 (89.7) | |
Number of case definition, n (%)c | # | < 0.001 | |
0 | 16 (4.7) | 5 (2.1) | |
1 | 48 (14.2) | 10 (4.1) | |
2 | 65 (19.3) | 25 (10.3) | |
3 | 110 (32.6) | 52 (21.5) | |
4 | 98 (29.1) | 150 (62.0) |
Symptoms
Dutch database (n = 337) | US database (n = 252) | |||
---|---|---|---|---|
Composite score Mean (SD) | Participants at 2/2 threshold (%) | Composite score Mean (SD) | Participants at 2/2 threshold (%) | |
Fatigue/extreme tiredness | 75.4 (17.5) | 90.7 | 81.4 (15.1) | 98.4 |
Post-exertional malaise | ||||
Dead, heavy feeling after starting exercise | 50.1 (26.9) | 58.3 | 76.2 (24.7) | 87.7 |
Next-day soreness or fatigue after everyday activities | 66.6 (20.8) | 80.7 | 75.3 (21.6) | 90.9 |
Mentally tired after the slightest effort | 61.7 (23.7) | 72.8 | 68.2 (23.0) | 86.1 |
Physically tired after minimum exercise | 67.0 (21.7) | 81.2 | 77.8 (20.6) | 92.9 |
Physically drained or sick after mild activity | 59.8 (22.8) | 70.3 | 73.2 (22.5) | 88.9 |
Muscle fatigue after mild physical activity | 63.1 (25.7) | 74.4 | 72.2 (26.1) | 86.1 |
Worsening of symptoms after mild physical activity | 67.7 (23.7) | 78.5 | 78.8 (21.9) | 92.9 |
Worsening of symptoms after mild mental activity | 59.1 (25.9) | 66.5 | 63.4 (27.0) | 76.6 |
Difficulty reading (dyslexia) after mild physical or mental activity | 41.2 (30.8) | 40.6 | 44.6 (33.4) | 49.2 |
Sleep | ||||
Unrefreshing sleep | 73.9 (22.3) | 88.0 | 81.7 (19.1) | 94.8 |
Need to nap daily | 56.2 (32.3) | 56.4 | 58.1 (30.0) | 66.7 |
Problems falling asleep | 47.4 (28.0) | 49.9 | 55.9 (29.3) | 63.9 |
Problems staying asleep | 52.7 (28.6) | 56.4 | 58.4 (30.5) | 65.1 |
Waking up early in the morning (e.g. 3 AM) | 43.2 (28.3) | 43.1 | 48.9 (30.2) | 49.6 |
Sleeping all day and staying awake all night | 18.4 (22.8) | 9.5 | 17.7 (27.2) | 16.3 |
Daytime drowsiness | 52.6 (26.9) | 55.3 | 63.2 (26.9) | 77.0 |
Pain | ||||
Pain or aching in muscles | 59.6 (24.8) | 70.0 | 67.8 (26.0) | 80.2 |
Joint pain | 51.1 (29.9) | 59.4 | 57.2 (32.9) | 64.7 |
Eye pain | 31.2 (24.6) | 24.8 | 31.8 (28.8) | 31.0 |
Chest pain | 23.1 (21.8) | 11.7 | 25.8 (25.7) | 19.0 |
Bloating | 38.2 (25.8) | 37.6 | 47.1 (28.1) | 50.4 |
Abdomen/stomach pain | 36.4 (23.2) | 30.8 | 42.1 (27.7) | 43.7 |
Headaches | 24.8 (23.8) | 42.8 | 50.5 (26.3) | 55.2 |
Aching of the eyes or behind the eyes | 29.0 (24.6) | 17.4 | 36.8 (29.8) | 36.9 |
Sensitivity to pain | 27.0 (30.0) | 24.0 | 51.3 (32.9) | 59.5 |
Myofascial pain | 15.7 (25.7) | 12.5 | 26.3 (34.0) | 30.2 |
Neurocognitive | ||||
Muscle twitches | 26.9 (22.3) | 16.6 | 34.4 (25.5) | 29.8 |
Muscle weakness | 44.7 (27.4) | 45.2 | 63.5 (27.2) | 74.6 |
Sensitivity to noise | 54.7 (26.8) | 57.8 | 61.0 (26.8) | 69.8 |
Sensitivity to bright lights | 47.3 (28.4) | 46.0 | 53.2 (29.0) | 55.6 |
Problems remembering things | 52.2 (22.5) | 58.0 | 67.9 (24.1) | 84.5 |
Difficulty paying attention for a long period of time | 60.8 (24.0) | 73.3 | 70.4 (24.3) | 86.1 |
Difficulty finding the right word to say, or expressing thoughts | 48.5 (22.4) | 50.7 | 61.1 (24.7) | 75.4 |
Difficulty understanding things | 33.3 (21.5) | 23.2 | 48.5 (25.1) | 55.2 |
Only able to focus on one thing at a time | 57.1 (25.2) | 67.6 | 64.9 (25.1) | 78.6 |
Unable to focus vision | 21.5 (23.6) | 13.6 | 35.1 (27.4) | 31.7 |
Unable to focus attention | 34.6 (22.9) | 27.2 | 50.9 (25.1) | 63.1 |
Loss of depth perception | 18.5 (25.6) | 11.7 | 24.0 (29.5) | 21.4 |
Slowness of thought | 47.3 (26.4) | 50.7 | 56.9 (25.5) | 71.4 |
Absent-mindedness or forgetfulness | 44.0 (22.6) | 43.3 | 60.7 (24.5) | 78.6 |
Feeling disoriented | 20.2 (22.7) | 11.2 | 35.9 (25.3) | 29.4 |
Slowed speech | 21.3 (22.7) | 12.0 | 32.6 (27.1) | 31.3 |
Poor coordination | 30.0 (25.1) | 21.3 | 46.2 (28.6) | 52.8 |
Autonomic | ||||
Bladder problems | 22.1 (28.0) | 18.3 | 35.6 (32.5) | 34.5 |
Urinary urgency | 34.5 (27.6) | 31.3 | 39.7 (31.2) | 42.9 |
Waking up at night to urinate | 51.2 (29.2) | 49.6 | 45.7 (32.0) | 46.4 |
Irritable bowel problems | 39.8 (29.7) | 42.2 | 49.1 (32.7) | 55.6 |
Nausea | 28.4 (21.5) | 16.6 | 33.8 (26.9) | 30.6 |
Feeling unsteady on feet | 34.2 (24.1) | 23.7 | 44.0 (28.8) | 46.4 |
Shortness of breath or trouble catching breath | 27.9 (22.2) | 17.7 | 39.8 (28.0) | 37.7 |
Dizziness or fainting | 31.3 (22.2) | 19.6 | 42.1 (27.6) | 43.7 |
Irregular heart beats | 27.8 (23.0) | 16.1 | 30.4 (26.8) | 28.6 |
Heart beats quickly after standing | 31.3 (28.9) | 27.0 | 43.8 (32.6) | 46.0 |
Blurred or tunnel vision after standing | 21.9 (26.4) | 16.6 | 30.5 (31.2) | 29.0 |
Graying or blacking out after standing | 32.5 (24.2) | 23.2 | 22.7 (28.1) | 17.5 |
Inability to tolerate an upright position | 27.3 (27.9) | 18.3 | 46.7 (34.3) | 52.0 |
Neuroendocrine | ||||
Losing weight without trying | 7.1 (16.7) | 4.1 | 13.2 (21.9) | 7.5 |
Gaining weight without trying | 18.3 (25.8) | 13.9 | 36.3 (36.6) | 41.3 |
Lack of appetite | 19.3 (21.4) | 11.4 | 30.3 (25.8) | 25.4 |
Sweating hands | 12.9 (21.2) | 8.2 | 16.6 (25.7) | 13.1 |
Night sweats | 33.0 (27.3) | 29.2 | 36.1 (30.5) | 31.3 |
Cold limbs | 51.9 (26.4) | 58.3 | 46.9 (29.9) | 48.4 |
Feeling chills or shivers | 31.7 (23.1) | 21.5 | 34.0 (26.3) | 32.9 |
Feeling hot or cold for no reason | 42.4 (24.8) | 38.7 | 51.7 (26.9) | 61.1 |
Felling like you have a high temperature | 29.6 (22.6) | 19.3 | 33.0 (27.2) | 29.4 |
Feeling like you have a low temperature | 20.7 (25.5) | 15.8 | 24.7 (26.7) | 21.8 |
Alcohol intolerance | 15.1 (30.8) | 14.2 | 40.1 (36.9) | 34.1 |
Intolerance to extremes of temperature | 42.3 (35.0) | 41.7 | 64.9 (31.1) | 72.2 |
Fluctuations in temperature throughout the day | 30.3 (28.5) | 26.4 | 45.2 (31.8) | 48.0 |
Immune | ||||
Sore throat | 30.1 (20.4) | 17.4 | 37.3 (25.7) | 32.9 |
Tender/sore lymph nodes | 23.4 (22.9) | 14.4 | 37.5 (30.5) | 36.5 |
Fever | 9.2 (16.9) | 1.6 | 16.1 (22.1) | 9.9 |
Flu-like symptoms | 36.1 (23.7) | 28.3 | 51.8 (27.3) | 57.1 |
Sensitivity to smells, food, medications, or chemicals | 25.6 (27.1) | 19.1 | 45.0 (32.7) | 46.8 |
Viral infections with prolonged recovery periods | 16.9 (24.7) | 9.5 | 35.0 (32.7) | 32.5 |
Sinus infections | 15.2 (24.0) | 10.4 | 21.9 (26.2) | 19.4 |
Others | ||||
Sensitivity to mold | 18.3 (28.9) | 16.6 | 27.2 (36.3) | 30.6 |
Sensitivity to vibration | 22.9 (29.9) | 18.3 | 30.6 (35.0) | 32.9 |
Symptom-based clusters
-
Participants in Cluster 2 (n = 24) were characterized by low frequency and severity scores for problems related to dizziness/fainting, stomach ache and problems staying asleep.
-
Participants in Cluster 4 (n = 23) were characterized by low frequency and severity scores for urinary problems and higher frequency scores for increased heart rate by standing.
-
Participants in Cluster 7 (n = 30) were characterized by increased frequency scores for cognitive impairments.
-
Participants in Cluster 9 (n = 26) were characterized by high frequency and severity scores for dizziness/fainting, feeling unsteady on their feet and sensitivity/intolerance to smell and alcohol.
-
Participants in Cluster 11 (n = 17) were characterized by high frequency and severity scores for impaired day–night rhythm but low frequency and severity scores for muscle weakness and coordination problems.
-
Participants in Cluster 19 (n = 19) were characterized by low frequency scores for physical fatigue, symptoms after exercise and irritable bowel problems.
-
Participants in Cluster 24 (n = 43) were characterized by high frequency and severity scores for sensitivity to sound, sleeping problems and symptoms after exercise.
-
Participants in Cluster 26 (n = 18) were characterized by a relatively high symptom burden combined with high frequency and severity scores for temperature related symptoms and pressure pain.
-
Participants in Cluster 28 (n = 38) were characterized by a relatively low symptom burden and low frequency and severity scores for muscle related problems.
-
Participants in Cluster 31 (n = 15) were characterized by high frequency and severity scores for sensitivity/intolerance to mold and temperature and stomach/bowel problems.
-
Participants in Cluster 36 (n = 10) had the highest symptom burden (i.e. highest frequency and severity of symptoms).
-
Participants in Cluster 37 (n = 18) had the lowest symptom burden (i.e. lowest frequency and severity of symptoms).
-
Participants in Cluster 40 (n = 20) were characterized by low frequency and severity scores for symptoms after physical and mental exercise, muscle fatigue and problems with focus on one thing.
Cluster 2 (n = 24) | Cluster 4 (n = 23) | Cluster 7 (n = 30) | Cluster 9 (n = 26) | Cluster 11 (n = 17) | Cluster 19 (n = 19) | Cluster 24 (n = 43) | Cluster 26 (n = 18) | Cluster 28 (n = 38) | Cluster 31 (n = 15) | Cluster 36 (n = 10) | Cluster 37 (n = 18) | Cluster 40 (n = 20) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sex, n (%) | |||||||||||||
Male | 6 (25.0) | 2 (8.7) | 8 (26.7) | 4 (15.4) | 6 (35.3) | 8 (42.1) | 4 (9.3) | 3 (16.7) | 2 (5.3)1 | 3 (20.0) | 1 (10.0) | 6 (33.3) | 2 (10.0) |
Female | 18 (75.0) | 21 (91.3) | 22 (73.3) | 22 (84.6) | 11 (64.7) | 10 (52.6) | 39 (90.7) | 15 (83.3) | 36 (94.7) | 12 (80.0) | 9 (90.0) | 12 (66.7) | 17 (85.0) |
Other/I don’t want to say | – | – | – | – | – | 1 (5.3) | – | – | – | – | – | – | 1 (5.0) |
Age, years | 52 (47–61) | 38 (27–48)2 | 55 (45–58) | 55 (39–60) | 51 (39–62) | 60 (50–70) | 59 (51–64) | 52 (44–61) | 57 (39–63) | 52 (43–59) | 52 (41–58) | 61 (53–71) | 62 (52–70) |
BMI, kg/m2 | 24.6 (21.4–29.0) | 20.9 (20.3–27.6) | 26.0 (21.7–30.7) | 23.4 (21.9–26.5) | 24.0 (19.6–26.2) | 25.9 (21.5–31.2) | 24.5 (22.3–28.6) | 23.5 (21.2–26.1) | 24.2 (21.4–29.6) | 21.3 (20.3–25.3) | 22.7 (21.0–27.9) | 25.4 (22.8–26.8) | 22.4 (19.8–28.1) |
Ethnicity, n (%) | |||||||||||||
Black, African-American | 1 (4.2) | – | – | – | – | – | – | – | – | – | – | – | – |
White | 22 (91.7) | 23 (100.0) | 29 (96.7) | 24 (92.3) | 17 (100.0) | 18 (94.7) | 43 (100.0) | 17 (94.4) | 37 (97.4) | 15 (100.0) | 9 (90.0) | 18 (100.0) | 19 (95.0) |
American Indian/Alaska Native | – | – | – | – | – | – | – | – | – | – | – | – | – |
Asian or Pacific Islander | 1 (4.2) | – | – | – | – | – | – | – | – | – | 1 (10.0) | – | – |
Other | – | – | 1 (3.3) | 2 (7.7) | – | 1 (5.3) | – | 1 (5.6) | 1 (2.6) | – | – | – | 1 (5.0) |
Marital status, n (%) | |||||||||||||
Married or living with partner | 15 (62.5) | 9 (39.1) | 16 (53.3) | 13 (50.0) | 8 (47.1) | 8 (42.1) | 27 (62.8) | 13 (72.2) | 22 (57.9) | 12 (80.0) | 2 (20.0) | 8 (44.4) | 13 (65.0) |
Living alone | 8 (33.3) | 12 (52.2) | 10 (33.3) | 11 (42.3) | 8 (47.1) | 7 (36.8) | 14 (32.6) | 5 (27.8) | 15 (39.5) | 3 (20.0) | 6 (60.0) | 8 (44.4) | 6 (30.0) |
Widow(er)/divorced | 1 (4.2) | 2 (8.7) | 4 (13.3) | 2 (7.7) | 1 (5.9) | 4 (21.1) | 2 (4.7) | – | 1 (2.6) | – | 2 (20.0) | 2 (11.1) | 1 (5.0) |
Children, n (%) | |||||||||||||
No | 12 (50.0) | 16 (69.6) | 16 (53.3) | 15 (57.7) | 9 (52.9) | 9 (47.4) | 24 (55.8) | 9 (50.0) | 22 (57.9) | 8 (53.3) | 4 (40.0) | 7 (38.9) | 9 (45.0) |
Yes | 12 (50.0) | 7 (30.4) | 14 (46.7) | 11 (42.3) | 8 (47.1) | 10 (52.6) | 19 (44.2) | 9 (50.0) | 16 (42.1) | 7 (46.7) | 6 (60.0) | 11 (61.1) | 11 (55.0) |
Education level, n (%)a | |||||||||||||
Low | 1 (4.2) | – | – | – | – | 2 (10.5) | 1 (2.3) | 3 (16.7) | 1 (2.6) | – | 1 (10.0) | 1 (5.6) | – |
Medium | 7 (29.2) | 8 (34.8) | 13 (43.3) | 9 (34.6) | 6 (35.3) | 10 (52.6) | 19 (44.2) | 6 (33.3) | 10 (26.3) | 7 (46.7) | 5 (50.0) | 1 (5.6) | 7 (35.0) |
High | 16 (66.7) | 14 (60.9) | 17 (56.7) | 16 (61.5) | 11 (64.7) | 7 (36.8) | 23 (53.5) | 9 (50.0) | 27 (71.1) | 8 (53.3) | 4 (40.0) | 15 (83.3) | 13 (65.0) |
Other/I don’t want to say | – | 1 (4.3) | – | 1 (3.8) | – | – | – | – | – | – | – | 1 (5.6) | – |
Current work status, n (%)b | |||||||||||||
On disability | 16 (66.7) | 19 (82.6) | 25 (83.3) | 18 (69.2) | 12 (70.6) | 7 (36.8) | 31 (72.1) | 14 (77.8) | 18 (47.4) | 8 (53.3) | 10 (100.0) | 4 (22.2)3 | 10 (50.0) |
Student | – | 2 (8.7) | – | – | – | – | – | 1 (5.6) | – | 1 (6.7) | – | 1 (5.6) | – |
Homemaker | 3 (12.5) | 1 (4.3) | 1 (3.3) | 1 (3.8) | 2 (11.8) | 1 (5.3) | 9 (20.9) | 1 (5.6) | 1 (2.6) | 2 (13.3) | – | – | 3 (15.0) |
Retired | 1 (4.2) | – | 1 (3.3) | 3 (11.5) | 2 (11.8) | 8 (42.1)4 | 7 (16.3) | 2 (11.1) | 6 (15.8) | 3 (20.0) | 1 (10.0) | 8 (44.4)4 | 7 (35.0) |
Unemployed | 3 (12.5) | 1 (4.3) | – | – | 2 (11.8) | 1 (5.3) | 3 (7.0) | 1 (5.6) | 4 (10.5) | 1 (6.7) | – | 1 (5.6) | 2 (10) |
Working part-time | 10 (41.7)5 | 2 (8.7) | –5 | 4 (15.4) | 3 (17.6) | 2 (10.5) | 5 (11.6) | 1 (5.6) | 11 (28.9) | 2 (13.3) | 1 (10.0) | 5 (27.8) | 6 (30.0) |
Working full-time | 1 (4.2) | – | 3 (10.0) | – | – | 2 (10.5) | – | – | 2 (5.3) | – | – | 1 (5.6) | - |
Case definition, n (%) | |||||||||||||
Fukuda Criteria | 20 (83.3) | 21 (91.3) | 26 (86.7) | 26 (100.0) | 17 (100.0) | 16 (84.2) | 39 (90.7) | 15 (83.3) | 34 (89.5) | 14 (93.3) | 5 (50.0)6 | 17 (94.4) | 20 (100.0) |
Canadian Clinical ME/CFS Criteria | 12 (50.0) | 15 (65.2) | 26 (86.7) | 26 (100.0) | 9 (52.9) | 3 (15.8)7 | 35 (81.4) | 13 (72.2) | 6 (15.8)7 | 11 (73.3) | 5 (50.0) | –7 | 9 (45.0) |
International Consensus Criteria | 3 (12.5) | 6 (26.1) | 14 (46.7) | 21 (80.8)8 | 6 (35.3) | 3 (15.8) | 19 (44.2) | 18 (100.0)9 | 1 (2.6) | 6 (40.0) | 10 (100.0)8 | – | 8 (40.0) |
Institute of Medicine | 19 (79.2) | 21 (91.3) | 26 (86.7) | 26 (100.0) | 17 (100.0) | 12 (63.2) | 39 (90.7) | 15 (83.3) | 26 (68.4) | 14 (93.3) | 5 (50.0) | 4 (22.2)10 | 16 (80.0) |
Nr. of case definition, n (%) | |||||||||||||
0 | 3 (12.5) | 2 (8.7) | 2 (6.7) | – | – | 2 (10.5) | 1 (2.3) | – | 3 (7.9) | – | – | 1 (5.6) | – |
1 | 1 (4.2) | – | 2 (6.7) | – | – | 5 (26.3) | 3 (7.0) | 3 (16.7) | 9 (23.7) | 1 (6.7) | 5 (50.0) | 13 (72.2)11 | 2 (10.0) |
2 | 9 (37.5) | 2 (8.7) | – | – | 6 (35.3) | 7 (36.8) | 4 (9.3) | – | 20 (52.6)12 | 2 (13.3) | – | 4 (22.2) | 7 (35.0) |
3 | 9 (37.5) | 11 (47.8) | 14 (46.7) | 5 (19.2) | 7 (41.2) | 5 (26.3) | 19 (44.2) | 2 (11.1) | 6 (15.8) | 8 (53.3) | –13 | – | 7 (35.0) |
4 | 2 (8.3) | 5 (21.7) | 12 (40.0) | 21 (80.8)14 | 4 (23.5) | – | 16 (37.2) | 13 (72.2)10 | – | 4 (26.7) | 5 (50.0) | – | 4 (20.0) |
Number or reported symptoms, median (IQR)c | 22 (19–27)15 | 28 (23–31)16 | 38 (34–43) | 41 (36–44) | 23 (21–26)15 | 17 (14–22)15 | 31 (27–34)16 | 45 (41–53) | 15 (11–19)17 | 28 (25–32)16 | 61 (59–62) | 8 (4–11)18 | 21 (17–26)15 |